Morimoto M, Numata K, Sugimori K, Shirato K, Kokawa A, Oka H, Hirasawa K, Koh R, Nihommatsu H, Tanaka K. Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma. World J Gastroenterol 2007; 13(7): 1003-1009 [PMID: 17373733 DOI: 10.3748/wjg.v13.i7.1003]
Corresponding Author of This Article
Manabu Morimoto, MD, Gastro-enterological Center, Yokohama City University Medical Center, 4-57, Urafunecho, Minami-ku, Yokohama City, 232-0024, Japan. morimoto@urahp.yokohama-cu.ac.jp
Article-Type of This Article
Liver Cancer
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/